Cargando…

Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma

BACKGROUND: Incidence and mortality of pancreatic ductal adenocarcinoma (PDAC) are on the rise. Sarcopenia and sarcopenic obesity have proven to be prognostic factors in different types of cancers. In the context of previous findings, we evaluated the impact of body composition in patients undergoin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruber, Elisabeth S., Jomrich, Gerd, Tamandl, Dietmar, Gnant, Michael, Schindl, Martin, Sahora, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502449/ https://www.ncbi.nlm.nih.gov/pubmed/31059520 http://dx.doi.org/10.1371/journal.pone.0215915

Ejemplares similares

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Sarcopenia and Sarcopenic Obesity
por: Choi, Kyung Mook
Publicado: (2013)

Sarcopenia and sarcopenic obesity
por: Choi, Kyung Mook
Publicado: (2016)

The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer
por: Gruber, Elisabeth S., et al.
Publicado: (2019)

Surgery for chronic pancreatitis: the comparison of two high-volume centers reveals lack of a uniform operative management
por: Surci, Niccolò, et al.
Publicado: (2021)

Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience
por: Surci, Niccolò, et al.
Publicado: (2023)

Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Editorial: (Osteo)Sarcopenia & sarcopenic obesity
por: Masiero, Stefano, et al.
Publicado: (2023)

Sarcopenia and Sarcopenic Obesity in Patients with Muscular Dystrophy
por: Merlini, Luciano, et al.
Publicado: (2014)

Inflammatory response and oxidative stress during liver resection
por: Schwarz, Christoph, et al.
Publicado: (2017)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Sarcopenia and Sarcopenic Obesity in Patients Undergoing Orthopedic Surgery
por: Ji, Hyung-Min, et al.
Publicado: (2016)

Uncertainty and Diversity in the Methods Defining Sarcopenia and Sarcopenic Obesity
por: Kim, Kyoung Min
Publicado: (2017)

The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer
por: Şahin, Muzaffer Ece Hakan, et al.
Publicado: (2023)

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II
por: Kostoglou-Athanassiou, Ifigenia, et al.
Publicado: (2023)

Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection
por: Lodewick, Toine M, et al.
Publicado: (2015)

The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases
por: Runkel, M., et al.
Publicado: (2021)

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy
por: Schindl, M., et al.
Publicado: (2018)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment
por: Nagano, A., et al.
Publicado: (2021)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Author’s Reply: The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases
por: Runkel, Mira
Publicado: (2021)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
por: Chen, Haoda, et al.
Publicado: (2021)

CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Characterization of Ageing- and Diet-Related Swine Models of Sarcopenia and Sarcopenic Obesity
por: Garcia-Contreras, Consolacion, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9bdch328nripahgoil69392jgv